Europe

Aurobindo Pharma is one of the leading generic pharma companies in Europe. It ranks among the top 10 generic companies in EU/UK (source: IQVIA data MAT Q4 2024). It is also the largest Indian Pharma company in terms of revenue from Europe (source: IQVIA data MAT Q4 2024).

The company has a full-fledged Pharmacy, Hospital and Tender sales infrastructure and operations in 10 countries (France, Germany, UK, Spain, Portugal, Italy, Netherlands, Belgium, Poland and Malta) with commercialized 550+ INNs thus addressing more than 80% of total European pharmaceutical market.

Our large product portfolio covers a broad base of therapeutic segments including CVS, CNS, Gastrointestinal, Antibiotics, Respiratory, Anti-diabetics, Pain management, Oncology, local anaesthetics, as well as commodity OTC and food supplements. We are also uniquely positioned to benefit from inhouse API capabilities for a wide range of products.

Our commercial infrastructure for Europe includes

High-capacity batch testing and release facility at Malta with testing capabilities for Oral solids (Over 16,000 batches per year), Sterile injectables and Oncology products (Over 1,000 batches per year).

Logistics Hub/ Warehouse near Lyon, France with over 25,000 square metres space.

High quality oral products manufacturing site in Portugal (Generis) with a capacity of producing 1.2 billion units (tablets, sachets or capsules).

Our strength in our key markets uniquely positions us to cater to the demand of a wide range of pharmaceutical products across the continent.

France France

France leads a strong presence with a team of over 123 Reps and KAMs covering Hospitals, Branded, Retail and OTC markets.Rank #1 by volume for hospital segment; #5 in the retail market.

PORTUGAL PORTUGAL

Leading presence in Hospital and Retail segments with a strong nation-wide field force. Rank #1: Gx Retail in value and units; Rank #1 Total Retail Total Market units; Rank #1 Hospital Market in units; Rank #1 Total Hospital Total Market units.

High quality Oral Dosage Forms, manufactured in Generis, Portugal manufacturing site, with a capacity for 1.2 billion units (Tablets and Capsules)

POLAND POLAND

Well-established presence in Retail reimbursement as well as non-reimbursement market, OTC, Food Supplement and Hospital segment, covering 22 therapeutic areas. Strong field-force team of > 160. A market leader in Urology.

Since 2020, Aurovitas Poland has operated its own pharmaceutical warehouse, streamlining logistics processes and improving product availability for patients nationwide.

ITALY ITALY

Established presence in Retail and Hospital, with a field force having a nation-wide coverage of pharmacies.Rank #8 in the market; fastest growing generic company.

UK UK

Strong presence in retail, covering top wholesalers , pharmacy groups, and NHS (tenders). Also recognized as one of the leading suppliers and distributors of generic pharmaceutical products in the UK.

GERMANY GERMANY

Established presence in Retail and Hospital. Rank #7 in retail segment.

SPAIN SPAIN

Established presence in Retail and Hospital. 9th largest generic company;fastest growing among Top 20 generic companies.

NETHERLANDS THE NETHERLANDS

Leading presence in Retail pharmacies, OTC, and Hospital. Strong growth in dose dispensing market (note: still higher than market growth; #1 since 2024). 2nd largest in retail pharmacy market (note: MAT JUL 2025; volume. In value (@PPP) # 4)). Ranked # 1 in OTC segment.

BELGIUM BELGIUM

5th largest generic company in retail segment.

We have a robust product pipeline including upcoming launches in Day-1s, injectables, respiratory, biosimilar and other niche segments.

Footer Logo

REGISTERED OFFICE

Plot no. 2, Maitrivihar, Ameerpet, Hyderabad-500038, Telangana, India.

CORPORATE OFFICE

Galaxy, Floors: 22-24, Plot No.1, Survey No.83/1, Hyderabad Knowledge City,
Raidurg Panmaktha, Rangareddy District,
Hyderabad - 500032, Telangana, India.

© Copyright 2025 Aurobindo Pharma Limited. All rights reserved.